Chris Bell

Vice President at Prime Medicine

Chris Bell has over 25 years of work experience, starting in 1994 as an Intern at Abbott Laboratories. Chris then worked at various pharmaceutical companies, including Pharmacia and Upjohn as a Microbiologist, Pharmacia as an Inspection Readiness Team Leader, and Pfizer Pharmaceuticals as a Quality Systems Manager and Auditor. In 2007, they joined Cayman Chemical as a Quality Assurance Manager. From 2012 to 2019, they worked at Emergent BioSolutions, holding roles such as Director of Quality Assurance and ultimately becoming the Vice President of Quality Systems and Compliance. Chris then joined Rocket Pharmaceuticals in 2019 as Vice President of Quality Assurance. In 2022, they joined Prime Medicine, Inc. as Vice President. Throughout their career, Chris Bell has amassed extensive experience in quality assurance, compliance, and pharmaceutical quality management systems.

Chris Bell attended the University of Wisconsin-Madison from 1991 to 1995, where they obtained a Bachelor of Science degree in Bacteriology.

Location

Cambridge, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Prime Medicine

4 followers

Prime Medicine was founded to bring the promise of gene editing to patients. We use Prime Editing, a next-generation technology that can “search and replace” to restore normal genetic function almost anywhere in the genome. Prime Editing searches to find the precise place in the genome to edit and replaces the segment of faulty DNA with a correct copy of DNA. A single Prime Editor can correct the individual mutations found across patients, meaning Prime Editing can potentially address more than 90 percent of known disease-causing genetic mutations. We envision a world where this technology can cure, halt, and ultimately prevent genetic diseases, providing lifelong benefit to patients. Prime Medicine offers the opportunity to shape the future of gene editing and transform how medicines are used to treat disease. Realizing the promise of Prime Editing requires a talented team with diversity of viewpoints and expertise. We’re building a group of dedicated, scientifically curious individuals who are passionate about helping patients live longer, healthier lives.


Industries

Employees

51-200

Links